LONG-TERM SURVIVAL OF SUSTAINED VIROLOGIC RESPONDERS TO PEGYLATED INTERFERON THERAPY FOR CHRONIC HEPATITIS C

被引：0
|
作者：
Chandok, Natasha [1 ]
Kim, W. Ray [1 ]
Pedersen, Rachel [2 ]
Therneau, Terry M. [2 ]
Canterbury, Katherine [1 ]
Stadheim, Linda M. [1 ]
Gross, John B. [1 ]
Poterucha, John J. [1 ]
机构：
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA
[2] Mayo Clin, Coll Med, Div Biomed Stat & Informat, Rochester, MN USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
119
引用
收藏
页码：359A / 360A
页数：2
相关论文
共 50 条
  • [21] HCV relapse in sustained responders to interferon therapy for chronic hepatitis C genotype 4
    El-Raziky, M.
    El-Akel, W.
    Soliman, M.
    El-Kafrawy, S.
    Abdel-Hamid, M.
    Esmat, G.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S141 - S141
  • [22] Retransplantation for hepatitis C-related cirrhosis under long-term pegylated interferon therapy
    Suárez, F
    Otero, A
    Gonzalez, B
    Gómez-Gutiérrez, M
    Arnal, F
    Vazquez, JL
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (03) : 775 - 777
  • [23] Delayed sustained virologic response after treatment of hepatitis C with pegylated interferon and ribavirin
    Yarze, Joseph C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S273 - S273
  • [24] CAN CHRONIC HCV INFECTION TERMINATE IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS LONG-TERM RESPONDERS TO INTERFERON THERAPY
    MORISCO, F
    TUCCILLO, C
    SESSA, G
    IASEVOLI, P
    FORESTIERI, MC
    DELVECCIOBLANCO, G
    CAPORASO, N
    GASTROENTEROLOGY, 1995, 108 (04) : A1126 - A1126
  • [25] Chronic hepatitis C long-term responders to human leukocyte interferon-α therapy:: persistence of a sustained biochemical and virological response during 5 years of surveillance
    Morisco, F
    Tuccillo, C
    Iasevoli, P
    Sessa, G
    Brunasso, G
    Caporaso, N
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (05) : 399 - 403
  • [26] Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients
    Giannini, E. G.
    Basso, M.
    Savarino, V.
    Picciotto, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (04) : 502 - 508
  • [27] Long-term survival and liver-related events after pegylated interferon/ribavirin therapy in HIV-infected patients with chronic hepatitis C
    Labarga, Pablo
    Fernandez-Montero, Jose V.
    de Mendoza, Carmen
    Barreiro, Pablo
    Soriano, Vincent
    ANTIVIRAL THERAPY, 2015, 20 (01) : 65 - 72
  • [28] DURABILITY OF SUSTAINED VIROLOGIC RESPONSE IN COMBINATION THERAPY WITH INTERFERON/PEGINTERFERON AND RIBAVIRIN FOR CHRONIC HEPATITIS C
    Il Lee, Jung
    Lee, Jin-Woo
    Kim, Young Soo
    Shin, Yong Woon
    Lee, Don Hoeng
    Kim, Hyung Gil
    Jeong, Seok
    Park, Hyung Joo
    Park, Hyun Shin
    Hong, Soon-Sun
    HEPATOLOGY, 2008, 48 (04) : 906A - 907A
  • [29] Long-term effects of interferon-based therapy for chronic hepatitis C
    Yu, Ming-Lung
    Huang, Chung-Feng
    Dai, Chia-Yen
    Huang, Jee-Fu
    Chuang, Wan-Long
    ONCOLOGY, 2007, 72 : 16 - 23
  • [30] Long-term Pegylated Interferon Monotherapy Following 72 Weeks of Pegylated Interferon and Ribavirin in Hepatitis C Virus Genotype-1-infected Slow Responders
    Watanabe, Shinya
    Kobayashi, Yoshimasa
    Kawata, Kazuhito
    Noritake, Hidenao
    Chida, Takeshi
    Nagasawa, Masamichi
    Kageyama, Fujito
    Kawamura, Kinya
    Sasada, Yuzo
    Suda, Takafumi
    INTERNAL MEDICINE, 2015, 54 (03) : 273 - 279
12345